Medivation Competitors and Similar CompaniesClear all
CureVac's competitors and similar companies include Active Biotech and Candel Therapeutics.
 Active Biotech Active Biotech is a biotechnology company with a focus on neurodegenerative and inflammatory diseases and cancer. |  Candel Therapeutics Candel Therapeutics (formerly known as Advantagene) is a biopharmaceutical company developing cancer immunotherapies. | ||
Founding Date | Founding Date 2000 | Founding Date 1998 | Founding Date 1999 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Tübingen, DE HQ Ottignies Louvain La Neuve, BE Wiesbaden, DE Amsterdam, NL Basel, CH Boston, US | Locations Lund, SE HQ Lund, SE | Locations Needham, US HQ |
Employees | Employees 82517% decrease | Employees 517% decrease | Employees 50 |
Valuation ($) | Valuation ($) 648.3 m | Valuation ($) 21 m | Valuation ($) 176.8 m |
Financial | |||
Revenue (est.) | Revenue (est.) €535.2m (FY, 2024) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods €9.7m (FY, 2024) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit €534.4m (FY, 2024) | Gross profit N/A | Gross profit N/A |
Net income | Net income €162.2m (FY, 2024) | Net income (kr37.3m) (FY, 2025) | Net income ($38.2m) (FY, 2025) |
Operating ⚠ | |||
Phase I Trials Products | Phase I Trials Products 3 (May, 2020) | Phase I Trials Products 2 (FY, 2020) | Phase I Trials Products N/A |
Funding | |||
Total funding raised | Total funding raised $ 1.1b | Total funding raised N/A | Total funding raised $ 64.6m |
For sources of this data, please see the company profile
View Company Profiles
Active Biotech
HQ
Lund, SE
Employees
5↓ 17% decrease
Active Biotech is a biotechnology company with a focus on neurodegenerative and inflammatory diseases and cancer.
View companyCandel Therapeutics
HQ
Needham, US
Employees
50
Candel Therapeutics (formerly known as Advantagene) is a biopharmaceutical company developing cancer immunotherapies.
View company